Pharmacy benefit management

Democrats’ new “Medicare for all” bill would replace almost all private plans.

In the wake of the CVS-Aetna merger, Cigna-Express Scripts partnership and other deals, a new future is emerging in the benefits world.

The pharmacy giant said its results this year will be dragged down by rising costs and poor results from a 2015 takeover of pharmacy company Omnicare.

In the wake of the CVS-Aetna merger, Cigna-Express Scripts partnership and other deals, a new future is emerging in the benefits world.

The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.

The White House and HHS want to eliminate a “shadowy system of kickbacks” in the drug industry pipeline.

The administration’s proposal would be a boon for employers and employees — and bring actual drug costs into the light.

The administration’s proposal would be a boon for employers and employees — and bring actual drug costs into the light.

The Trump administration’s new prescription drug proposal is vital to correct an increasingly dysfunctional market for employer plan sponsors.

Under the proposal, safe-harbor protection would be allowed only for rebates on discounts offered directly to patients, and fixed-fee service arrangements between drugmakers and PBMs.

Walmart will leave CVS Health’s network that administers drug benefits for millions of Americans, in a dispute over costs that could roil the business of filling prescriptions.

Big pharma disruption and healthcare challenges and legislation are just a few of the big trends that will shape the benefits industry in 2019.

Helping clients tackle rising pharmacy costs, boosting voluntary enrollment and mergers were among the most viewed news items of the year.

While it’s still early to tell what the acquisition will mean for healthcare, many experts are skeptical it will drive down costs for employers or employees.

The more educated employees are about treatment options and their pricing, the more likely they'll be to better engage in healthcare.

The Avella acquisition came in the same quarter that UnitedHealth purchased Genoa Healthcare, a behavioral pharmacy chain, for about $2.5 billion.

The outrageous prices for exclusive medications are crippling our health plans and terrorizing families in pain.

The outrageous prices for exclusive medications are crippling our health plans and terrorizing families in pain.

The health insurer said it plans to sell its Medicare prescription drug business in a key step toward completing its $67.5 billion merger.